Drug profile · INN
formoterol fumarate
FORMOTEROL FUMARATE
formoterol fumarate (FORMOTEROL FUMARATE) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — formoterol fumarate
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 2
- Programs
- 1
- Data quality
- 0.89
Quick answer
formoterol fumarate (FORMOTEROL FUMARATE) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is formoterol fumarate?
formoterol fumarate (FORMOTEROL FUMARATE) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for formoterol fumarate?
FORMOTEROL FUMARATE is a marketed brand name for formoterol fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of formoterol fumarate?
formoterol fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.